^
No biomarker
Multiple Myeloma
No biomarker
SCCHN
EGFR exon 20 insertion
NSCLC
ER positive
HER2 Negative Breast Cancer
KRAS G12C
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
EGFR mutation
NSCLC
EGFR mutation
NSCLC
HER-2 exon 20 mutation
NSCLC
AFP elevation
HCC
KRAS mutation
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
NTRK3 fusion
Solid Tumor
NTRK2 fusion
Solid Tumor
NTRK1 fusion
Solid Tumor
High 4-gene inflammatory score
Mesothelioma
PPP2R2A mutation
Ovarian Cancer
FANCL mutation
Ovarian Cancer
CDK12 mutation
Ovarian Cancer
HER-2 positive
HER2 Positive Breast Cancer
MET exon 14 mutation
NSCLC
BRCA2 mutation
Pancreatic Cancer
BRCA1 mutation
Pancreatic Cancer
HER-2 positive
HER2 Positive Breast Cancer
HR positive
HER2 Positive Breast Cancer
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
HRD
Ovarian Cancer
HR positive
HER2 Negative Breast Cancer
BRCA1 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRAF V600E
NSCLC
BRCA2 mutation
Breast Cancer
BRCA1 mutation
Breast Cancer
ER positive
HER2 Negative Breast Cancer
RAD51C mutation
Ovarian Cancer
CHEK2 mutation
Ovarian Cancer
RAD51B mutation
Ovarian Cancer
BARD1 mutation
Ovarian Cancer
ATM mutation
Ovarian Cancer
PALB2 mutation
Ovarian Cancer
RAD51D mutation
Ovarian Cancer
BRIP1 mutation
Ovarian Cancer
ER positive
HER2 Negative Breast Cancer
BRCA1 mutation
Gallbladder Cancer
FGFR2 amplification
Gastric Cancer
PIK3CA mutation
HER2 Positive Breast Cancer
EGFR exon 20 insertion
NSCLC
EGFR exon 20 insertion
NSCLC
EGFR mutation
NSCLC
FGFR2 mutation
Cholangiocarcinoma
HER-2 mutation
NSCLC
PALB2 mutation
Breast Cancer
ER positive
HER2 Negative Breast Cancer
EGFR mutation
NSCLC
EGFR mutation
NSCLC
BRAF mutation
Melanoma
HER-2 positive
Gastric Cancer
HER-2 positive
HER2 Positive Breast Cancer
HR positive
HER2 Negative Breast Cancer
EGFR mutation
NSCLC
TMB-H
Melanoma
EGFR L858R + T790M
NSCLC
EGFR L858R + T790M
NSCLC
TMB-H
Gastric Cancer
EGFR T790M + exon 19 deletion
NSCLC
AR-V7 positive
Prostate Cancer
BRAF V600E
Melanoma
KRAS G12C + PD-L1 overexpression
NSCLC
MDM2 amplification
Liposarcoma
EGFR exon 19 deletion
NSCLC
EGFR L858R
NSCLC
CD74-ROS1 fusion
NSCLC
EGFR exon 20 insertion
NSCLC
DKK1 overexpression
Gastroesophageal Junction Adenocarcinoma
EGFR mutation + CREBBP mutation
Lung Non-Small Cell Squamous Cancer
PD-L1 overexpression
Gastric Cancer
HER-2 positive
Gastric Cancer
HER-2 positive
Gastrointestinal Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
RAD51D mutation
Breast Cancer
EGFR mutation + MET mutation
NSCLC
KIT mutation
Melanoma
KIT amplification
Melanoma
PTEN mutation
Melanoma
MSI-H/dMMR
Melanoma
EGFR T790M + exon 19 deletion
NSCLC
EGFR amplification
Gastric Cancer
EGFR amplification
Esophageal Cancer
STK11 mutation
Cervical Cancer
KMT2D mutation
Cervical Cancer
PIK3CA mutation
Cervical Cancer
DDR + EGFR mutation
NSCLC
HMOX1 overexpression
Lung Cancer
CDK4 amplification
Osteosarcoma
NKX2-1 expression + PD-L1 expression
Lung Non-Squamous Non-Small Cell Cancer
EPHA3 mutation
NSCLC
NOTCH mutation
Adenoid Cystic Carcinoma
ER D538G + ER positive
HER2 Negative Breast Cancer
ER E380Q + ER positive
HER2 Negative Breast Cancer
ER Y537N + ER positive
HER2 Negative Breast Cancer
ER Y537S + ER positive
HER2 Negative Breast Cancer
NF1 mutation
Melanoma
PIK3CA mutation + HR positive
HER2 Negative Breast Cancer
PIK3CA mutation + HR positive
HER2 Negative Breast Cancer
HR positive
Hormone Receptor Positive Breast Cancer
Chr del(13)(q12.12)
Gastric Cancer
SMARCA4 mutation
Gastric Cancer
BRCA2 mutation
Breast Cancer
BRCA1 mutation
Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
CTAG1A expression
GastroEsophageal Cancer
BRCA2 mutation
Ovarian Cancer
HER-2 positive
HER2 Positive Breast Cancer
BRCA1 mutation
Ovarian Cancer
PGR expression
Breast Cancer
NANOGNB mutation
Clear Cell Renal Cell Carcinoma
BRCA2 mutation
Prostate Cancer
ATM mutation
Prostate Cancer
CXCL13 elevation
Clear Cell Renal Cell Carcinoma
TNFSF13B elevation
Clear Cell Renal Cell Carcinoma
IL6 elevation
Clear Cell Renal Cell Carcinoma
PTEN mutation
Prostate Cancer
PTEN deletion
Prostate Cancer
HER-2 positive
Salivary Gland Cancer
BRAF V600E + ROS1 fusion
LUAD
BRAF V600E + ROS1 fusion
LUAD
EGFR mutation + GRM8 mutation
Lung Non-Small Cell Squamous Cancer
TNFRSF8 expression
T Cell Non-Hodgkin Lymphoma
TRIM3 overexpression
Estrogen Receptor Positive Breast Cancer
TRIM3 overexpression
Breast Cancer
No biomarker
NSCLC
No biomarker
Esophageal Cancer
No biomarker
Gastroesophageal Junction Adenocarcinoma
PD-L1 underexpression
NSCLC
FCGR3A 158F
HER2 Positive Breast Cancer
FCGR3A 158V
HER2 Positive Breast Cancer
KIT exon 17 mutation
GIST
KIT exon 13 mutation
GIST
KIT exon 9 mutation
GIST
KIT exon 11 mutation
GIST
EGFR T790M
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
PD-L1 expression
Sarcoma
KRAS mutation
CRC
DKK1 overexpression
Gastroesophageal Junction Adenocarcinoma
DKK1 overexpression
Gastric Cancer
MET overexpression
Gastric Cancer
PD-L1 expression
NSCLC
HER-2 mutation
Ovarian Cancer
EGFR mutation
Ovarian Cancer
MYC amplification
Ovarian Cancer
IDH2 mutation
AML
IDH1 mutation
AML
RUNX1 mutation
AML
EGFR mutation + EGFR amplification
GBM
BRCA2 mutation
LUAD
EGFR L858R + PIK3CA H1047R + PIK3CA E545K
LUAD
MET overexpression + HER-2 overexpression
Gastric Cancer
HER-2 positive
HER2 Positive Breast Cancer
MYC amplification
Medulloblastoma
No biomarker
HL
ALK positive
NSCLC
MSI-H/dMMR
Endometrial Cancer
PIK3CA E542K + HR positive
HER2 Negative Breast Cancer
BCL2 overexpression
Multiple Myeloma
PD-L1 overexpression
Esophageal Squamous Cell Carcinoma
ACTA2 elevation
HER2 Positive Breast Cancer
PD-L1 overexpression
Gastric Cancer
PD-L1 overexpression
Gastroesophageal Junction Adenocarcinoma
EGFR exon 19 deletion
NSCLC
EGFR L858R
NSCLC
FLT3 mutation
AML
EGFR mutation
NSCLC
BRCA1 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
MSI-H/dMMR
Endometrial Cancer
BRCA1 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
Chr del(17p)
CLL
HR positive
HER2 Positive Breast Cancer
TP53 mutation
CLL
NPM1 mutation
AML
BRCA1 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
HR positive
HER2 Negative Breast Cancer
FLT3-ITD mutation
AML
CD20 expression
Childhood B Acute Lymphoblastic Leukemia
FLT3 mutation
AML
FOLR1 overexpression
Ovarian Cancer
HRD
Ovarian Cancer
GPX4 overexpression
Breast Cancer
ACSL4 overexpression
Breast Cancer
FOLR1 expression
Ovarian Cancer
FOLR1 expression
Endometrial Cancer
TP53 mutation
MDS
TP53 mutation
MDS
IDH2 mutation
MDS
ASXL1 mutation
MDS
MYC overexpression + IDH2 mutation
AML
MYC overexpression + IDH1 mutation
AML
MYC overexpression + IDH2 mutation
AML
MYC overexpression + IDH1 mutation
AML
CEBPA mutation
AML
VEGFA overexpression
Small Intestinal Carcinoma
HER-2 positive + HER-2 amplification
GastroEsophageal Cancer
Chr amplification(1q)
Multiple Myeloma
SPARC-L + IKZF3-H
Multiple Myeloma
CRBN-H + SPARC-L
Multiple Myeloma
YWHAE-JAZF1 fusion
Leiomyosarcoma
KRAS G12D + DNMT3A C559fsX
Sarcoma
Chr t(9;11)
CML
EGFR-SEPTIN14 fusion
NSCLC
BCL2 overexpression + CCND1 overexpression
Multiple Myeloma
FLT3-ITD mutation + FLT3 D835
AML
BRCA1 R1443*
Breast Cancer
BRCA1 2080delA + CCNE1 overexpression
Breast Cancer
BRCA1 2080delA + CCNE1 overexpression
Breast Cancer
BRCA1 2080delA
Breast Cancer
BRCA1 R1443*
Breast Cancer
KDM1A overexpression
Osteosarcoma
KDM1A overexpression
Rhabdomyosarcoma
KDM1A overexpression
Ewing Sarcoma
MYCN amplification
Neuroblastoma
BCL2 overexpression
Lung Cancer
BCL2 overexpression
Lung Cancer
BCL2 overexpression
Lung Cancer
BCL2 overexpression
Lung Cancer
CD38 expression
B Acute Lymphoblastic Leukemia
CD38 expression
T Acute Lymphoblastic Leukemia
FLT3-ITD mutation + FLT3 D835
AML
ABCG2 overexpression
Solid Tumor
ABCG2 overexpression
Solid Tumor
ABCG2 overexpression
Solid Tumor
No biomarker
RCC
No biomarker
Diffuse Large B Cell Lymphoma
No biomarker
Urothelial Cancer
PD-L1 overexpression
Lung Non-Squamous Non-Small Cell Cancer
BCR-ABL1 T315I
CML
BCR-ABL1 fusion
CML
HLA-A positive
Uveal Melanoma
IDH1 mutation
Cholangiocarcinoma
MSI-H/dMMR
CRC
MSI-H/dMMR
CRC
PD-L1 expression
Triple Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
BRAF V600
Melanoma
HR positive
HER2 Negative Breast Cancer
BRAF V600
NSCLC
EGFR mutation
NSCLC
MET positive
NSCLC
PD-L1 expression
Cervical Cancer
BRCA2 mutation
Prostate Cancer
HER-2 negative
HER2 Negative Breast Cancer
BRCA2 mutation
Breast Cancer
BRCA1 mutation
Breast Cancer
HAVCR2 expression
Nasopharyngeal Carcinoma
LAG3 expression
Nasopharyngeal Carcinoma
IFNG expression
Nasopharyngeal Carcinoma
SDHB mutation
GIST
PD-L1 negative
Cervical Cancer
EGFR mutation + PD-L1 overexpression
NSCLC
BRCA2 mutation
Breast Cancer
BRCA1 mutation
Breast Cancer
MSI-H/dMMR
Rectal Cancer
NR4A3 rearrangement + KIT mutation
Sarcoma
HER-2 overexpression
Endometrial Cancer
IDH1 mutation
Glioma
No biomarker
Multiple Myeloma
No biomarker
Diffuse Large B Cell Lymphoma
CD20 positive
CLL
EGFR exon 19 deletion
NSCLC
No biomarker
NSCLC
ALK positive
NSCLC
EGFR exon 19 deletion
NSCLC
PD-L1 expression
Triple Negative Breast Cancer
EGFR L858R
NSCLC
No biomarker
NSCLC
ALK positive
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
HER-2 amplification
Breast Cancer
KIT positive
GIST
HER-2 positive
HER2 Positive Breast Cancer
No biomarker
Malignant Pleural Mesothelioma
PD-L1 expression
NSCLC
ALK fusion
NSCLC
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
No biomarker
Follicular Lymphoma
No biomarker
Diffuse Large B Cell Lymphoma
No biomarker
Mediastinal B Cell Lymphoma
PDGFRA D842V
GIST
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
Esophageal Cancer
No biomarker
Esophageal Squamous Cell Carcinoma
No biomarker
Fallopian Tube Cancer
No biomarker
Ovarian Cancer
No biomarker
Peritoneal Cancer
No biomarker
Mantle Cell Lymphoma
PD-L1 expression
NSCLC
MSI-H/dMMR
Solid Tumor
No biomarker
Esophageal Adenocarcinoma
No biomarker
NHL
ALK positive
NSCLC
ROS1 fusion
NSCLC
No biomarker
Gastric Cancer
No biomarker
NSCLC
ALK positive
NHL
EGFR L858R
NSCLC
No biomarker
Small Cell Lung Cancer
EGFR T790M
NSCLC
EGFR exon 19 deletion
NSCLC
MET exon 14 mutation
NSCLC
PD-L1 overexpression
NSCLC
RET fusion
NSCLC
No biomarker
SCCHN
No biomarker
Gastric Adenocarcinoma
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
NSCLC
No biomarker
Breast Cancer
No biomarker
BCC
PD-L1 expression
Urothelial Cancer
EGFR mutation
NSCLC
EGFR L858R
NSCLC
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
No biomarker
Multiple Myeloma
No biomarker
Thyroid Gland Medullary Carcinoma
ALK positive
NSCLC
No biomarker
NSCLC
ROS1 positive
NSCLC
RET fusion
NSCLC
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
No biomarker
Small Cell Lung Cancer
HER-2 positive
Gastric Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
PD-L1 expression
NSCLC
IDH2 mutation
AML
No biomarker
AML
EGFR mutation
NSCLC
PD-L1 overexpression
NSCLC
No biomarker
HCC
No biomarker
HCC
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
No biomarker
Diffuse Large B Cell Lymphoma
RET fusion
Thyroid Gland Carcinoma
FGFR2 rearrangement
Cholangiocarcinoma
No biomarker
NSCLC
No biomarker
Lymphoma
No biomarker
Diffuse Large B Cell Lymphoma
No biomarker
B Acute Lymphoblastic Leukemia
No biomarker
Childhood B Acute Lymphoblastic Leukemia
No biomarker
Prostate Cancer
FGFR2 fusion
Cholangiocarcinoma
No biomarker
CLL
No biomarker
AML
No biomarker
NSCLC
No biomarker
Gastric Cancer
No biomarker
Urothelial Cancer
BRCA1 mutation
Peritoneal Cancer